State Street’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290M | Sell |
|
|||||
|
2025
Q1 | $266M | Sell |
|
|||||
|
2024
Q4 | $428M | Sell |
|
|||||
|
2024
Q3 | $351M | Buy |
|
|||||
|
2024
Q2 | $288M | Buy |
|
|||||
|
2024
Q1 | $229M | Sell |
|
|||||
|
2023
Q4 | $171M | Buy |
|
|||||
|
2023
Q3 | $163M | Buy |
|
|||||
|
2023
Q2 | $117M | Sell |
|
|||||
|
2023
Q1 | $173M | Buy |
|
|||||
|
2022
Q4 | $138M | Buy |
|
|||||
|
2022
Q3 | $120M | Buy |
|
|||||
|
2022
Q2 | $104M | Sell |
|
|||||
|
2022
Q1 | $146M | Sell |
|
|||||
|
2021
Q4 | $140M | Sell |
|
|||||
|
2021
Q3 | $171M | Buy |
|
|||||
|
2021
Q2 | $162M | Sell |
|
|||||
|
2021
Q1 | $191M | Sell |
|
|||||
|
2020
Q4 | $161M | Buy |
|
|||||
|
2020
Q3 | $149M | Buy |
|
|||||
|
2020
Q2 | $193M | Buy |
|
|||||
|
2020
Q1 | $138M | Buy |
|
|||||
|
2019
Q4 | $123M | Buy |
|
|||||
|
2019
Q3 | $81.9M | Sell |
|
|||||
|
2019
Q2 | $116M | Buy |
|
|||||
|
2019
Q1 | $167M | Buy |
|
|||||
|
2018
Q4 | $150M | Buy |
|
|||||
|
2018
Q3 | $206M | Buy |
|
|||||
|
2018
Q2 | $195M | Buy |
|
|||||
|
2018
Q1 | $130M | Sell |
|
|||||
|
2017
Q4 | $168M | Buy |
|
|||||
|
2017
Q3 | $124M | Buy |
|
|||||
|
2017
Q2 | $158M | Buy |
|
|||||
|
2017
Q1 | $145M | Buy |
|
|||||
|
2016
Q4 | $142M | Buy |
|
|||||
|
2016
Q3 | $31.2M | Buy |
|
|||||
|
2016
Q2 | $31.3M | Sell |
|
|||||
|
2016
Q1 | $40.1M | Sell |
|
|||||
|
2015
Q4 | $60.4M | Buy |
|
|||||
|
2015
Q3 | $43.2M | Sell |
|
|||||
|
2015
Q2 | $60M | Sell |
|
|||||
|
2015
Q1 | $68.4M | Buy |
|
|||||
|
2014
Q4 | $60.7M | Sell |
|
|||||
|
2014
Q3 | $64.3M | Buy |
|
|||||
|
2014
Q2 | $61.6M | Sell |
|
|||||
|
2014
Q1 | $62.2M | Sell |
|
|||||
|
2013
Q4 | $47.8M | Buy |
|
|||||
|
2013
Q3 | $38.8M | Buy |
|
|||||
|
2013
Q2 | $31.6M | Buy |
|